miDiagnostics
0641.984.602 · rovalta.com · 22/09/2026
ACTIVE
miDiagnostics
Financial year 2025 · closed on 31/12/2025
Net result
-12,6 M €
+32.2% YoY
Revenue
24,9 k €
+72.4% YoY
Equity
-10,6 M €
-631.5% YoY
Workforce
54,2 ETP
-21.0% YoY
Overview
What does miDiagnostics do?
miDiagnostics is a Public limited company incorporated in 2015. Its main activity is: Management consultancy activities. Its registered office is in Leuven. It employs on average 54,2 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0641.984.602
Incorporation
28/10/2015
Legal form
Public limited company
Registered office
Gaston Geenslaan 1
3001 Leuven · FlandreSee on map
3001 Leuven · FlandreSee on map
Contributed capital
1 994 396,51 €
Latest accounts
31/12/2025
Average workforce
54,2 ETP
Activities (NACE)
Joint committees (2)
- 100
- 200
Signals
Positive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||
| Revenue | 24,9 k € | +72.4% | 14,5 k € | +118% | 6,6 k € | -97.4% | 252,7 k € | +919% | 24,8 k € | – | – | – | |||
| EBITDA | 6,9 M € | +1608% | 405 k € | +110% | -4,2 M € | +58.3% | -10 M € | -328% | -2,3 M € | -6.4% | -2,2 M € | +52.7% | -4,6 M € | -57.6% | -2,9 M € |
| Operating result | -13,2 M € | +29.2% | -18,6 M € | +23.2% | -24,2 M € | +13.5% | -28 M € | -50.7% | -18,6 M € | -42.9% | -13 M € | +28.6% | -18,2 M € | +30.6% | -26,3 M € |
| Net result | -12,6 M € | +32.2% | -18,6 M € | +21.4% | -23,6 M € | +14.2% | -27,5 M € | -55.5% | -17,7 M € | -55.9% | -11,4 M € | +37.5% | -18,2 M € | +30.8% | -26,3 M € |
| Balance sheet | |||||||||||||||
| Equity | -10,6 M € | -632% | 2 M € | +252% | 566,9 k € | -96.0% | 14,1 M € | -15.3% | 16,6 M € | +148% | 6,7 M € | -62.9% | 18 M € | +11.3% | 16,2 M € |
| Total assets | 11,6 M € | -57.3% | 27,2 M € | +7.3% | 25,3 M € | -16.9% | 30,5 M € | +5.6% | 28,9 M € | +47.6% | 19,6 M € | -5.0% | 20,6 M € | -26.2% | 27,9 M € |
| Cash | 653 k € | -92.6% | 8,9 M € | +1553% | 536,6 k € | -85.7% | 3,7 M € | -68.8% | 12 M € | +85.7% | 6,5 M € | -46.1% | 12 M € | -7.3% | 13 M € |
| Debts | 21,9 M € | +11.1% | 19,7 M € | -11.7% | 22,4 M € | +36.5% | 16,4 M € | +45.5% | 11,3 M € | -6.4% | 12 M € | +370% | 2,6 M € | -78.2% | 11,7 M € |
| Other | |||||||||||||||
| Workforce | 54,2 ETP | -21.0% | 68,6 ETP | -7.2% | 73,9 ETP | -20.4% | 92,8 ETP | +26.1% | 73,6 ETP | +540% | 11,5 ETP | +125% | 5,1 ETP | +410% | 1,0 ETP |
Estimate
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 5 active · 35 ended
Active mandates
Active
Active
Peter Verhaeghe
ActiveVan den Bruinhorst Management Consultancy BV
ActiveEnded mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
ALIGOS BELGIUM● Active | 0702.969.886 |
Bio-Incubator Leuven● Active | 0876.605.232 |
Community Building Arenberg● Active | 1014.096.594 |
Creative Biolabs Belgium● Active | 1028.942.544 |
DName-iT● Active | 0506.754.823 |
Fisherman● Active | 0804.287.079 |
Fishway● Active | 0787.869.632 |
Formac Pharmaceuticals● Active | 0892.914.395 |
IDA INTERNATIONAL● Active | 1002.119.470 |
Lever Bio Belgium● Active | 1039.455.958 |
Maatschap reMYND● Active | 1019.655.090 |
Oxurion● Active | 0881.620.924 |
PALEO● Active | 0756.986.614 |
PARKEERGEBOUW● Active | 1009.039.728 |
Pledge Therapeutics● Active | 0726.743.301 |
Qmineral● Active | 0837.633.897 |
Raya Therapeutic● Active | 1003.128.171 |
ReGenesys● Active | 0877.070.337 |
ReGenesys EU● Active | 0544.577.301 |
reMYND● Active | 0476.910.101 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/06/2026 | 23/06/2025 | 11/07/2024 | 23/06/2023 | 01/07/2022 | 08/07/2021 |
| General meeting | 11/06/2026 | 12/06/2025 | 28/06/2024 | 08/06/2023 | 09/06/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
10 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 11/06/2026 | 24/06/2026 | Dutch | |
| Full model | 31/12/2024 | 12/06/2025 | 23/06/2025 | Dutch | |
| Full model | 31/12/2023 | 28/06/2024 | 11/07/2024 | Dutch | |
| Full model | 31/12/2022 | 08/06/2023 | 23/06/2023 | Dutch | |
| Full model | 31/12/2021 | 09/06/2022 | 01/07/2022 | Dutch | |
| Full model | 31/12/2020 | 10/06/2021 | 08/07/2021 | Dutch | |
| Full model | 31/12/2019 | 11/06/2020 | 16/06/2020 | Dutch | |
| Full model | 31/12/2018 | 13/06/2019 | 01/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 14/06/2018 | 24/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 22/06/2017 | 31/10/2017 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 5 active · 35 ended
Active mandates
Active
Active
Peter Verhaeghe
ActiveVan den Bruinhorst Management Consultancy BV
ActiveEnded mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates22/09/2025ONTSLAGEN - BENOEMINGEN
- Capital / shares01/07/2025KAPITAAL - AANDELEN
- Mandates02/01/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Capital / shares04/07/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates03/10/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates04/09/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares15/06/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Registered office12/04/2023MAATSCHAPPELIJKE ZETEL
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-12,6 M €↑
- 2024Annual accounts 2024-18,6 M €↑
- 2023Annual accounts 2023-23,6 M €↑
- 2022Annual accounts 2022-27,5 M €↓
- 2021Annual accounts 2021-17,7 M €↓
- 2018Annual accounts 2018-11,4 M €↑
- 2017Annual accounts 2017-18,2 M €↑
- 2016Annual accounts 2016-26,3 M €
- 28/10/2015IncorporationPublic limited company